Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
ACS Applied Materials & Interfaces|January 6, 2026
Macrocyclic Pyclen-Based Hybrid Nanoprobes for Magnetic Resonance Imaging of Sentinel Lymph Node MetastasisHaojie Gu, Yuting Jiang, Zhongyuan Cai, et al.Molecular Immunology|June 25, 2024
CD69<sup>+</sup> Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinomaHongqin You, Yixin Wang, Xiaokun Wang, et al.Cancer Innovation|October 29, 2024
Combination therapy using low-dose anlotinib and immune checkpoint inhibitors for extensive-stage small cell lung cancerHan Li, Shumin Yuan, Han Wu, et al.The Oncologist|March 29, 2022
Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory MelanomaShumin Yuan, Qiang Fu, Lingdi Zhao, et al.Immunity & Ageing : I & A|December 16, 2023
The inter-link of ageing, cancer and immunity: findings from real-world retrospective studyXiaomin Fu, Peng Qin, Fanghui Li, et al.Journal of Diabetes|May 11, 2023
Effects of first-line antidiabetic drugs on the improvement of arterial stiffness: A Bayesian network meta-analysisJincheng Wang, Yuhan Wang, Yueheng Wang, et al.Frontiers in Microbiology|April 12, 2024
Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysisPengcheng Liu, Jiehao Cai, He Tian, et al.Nano Letters|September 11, 2023
Relaxivity Enhancement of Hybrid Micelles via Modulation of Water Coordination Numbers for Magnetic Resonance LymphographyYuting Jiang, Zhongyuan Cai, Shengxiang Fu, et al.Frontiers in Oncology|September 26, 2022
Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancerBaozhen Ma, Yu Zhou, Yiman Shang, et al.Biomaterials|June 7, 2026
Hydrophilicity engineering of amphiphilic macrocyclic MRI contrast agents for enhanced hepatic targeting efficiencyYuting Jiang, Zhongyuan Cai, Haojie Gu, et al.Pageof 8